Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

The Toll-IL-1 receptor adaptor family grows to five members.

O'Neill LA, Fitzgerald KA, Bowie AG.

Trends Immunol. 2003 Jun;24(6):286-90. Review.

PMID:
12810098
2.

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S.

J Immunol. 2002 Dec 15;169(12):6668-72.

3.

The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.

McGettrick AF, O'Neill LA.

Mol Immunol. 2004 Jul;41(6-7):577-82. Review.

PMID:
15219996
4.

TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.

Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T.

J Biol Chem. 2003 Dec 12;278(50):49751-62. Epub 2003 Sep 30.

5.
6.

TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.

Seya T, Oshiumi H, Sasai M, Akazawa T, Matsumoto M.

Int J Biochem Cell Biol. 2005 Mar;37(3):524-9. Review.

PMID:
15618008
7.

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

O'Neill LA, Bowie AG.

Nat Rev Immunol. 2007 May;7(5):353-64. Review.

PMID:
17457343
9.

Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.

Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, H├Ącker G, Holzmann B, Heesemann J.

J Immunol. 2004 Sep 1;173(5):3320-8.

10.

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T.

Nat Immunol. 2003 Feb;4(2):161-7. Epub 2003 Jan 21.

PMID:
12539043
11.

Microbial recognition by Toll-like receptors.

Takeda K, Akira S.

J Dermatol Sci. 2004 Apr;34(2):73-82. Review.

PMID:
15033189
12.

Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.

Fornarino S, Laval G, Barreiro LB, Manry J, Vasseur E, Quintana-Murci L.

Mol Biol Evol. 2011 Nov;28(11):3087-97. doi: 10.1093/molbev/msr137. Epub 2011 Jun 9.

PMID:
21659570
13.

Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish.

Meijer AH, Gabby Krens SF, Medina Rodriguez IA, He S, Bitter W, Ewa Snaar-Jagalska B, Spaink HP.

Mol Immunol. 2004 Jan;40(11):773-83.

PMID:
14687934
14.

TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway.

Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S.

Nat Immunol. 2003 Nov;4(11):1144-50. Epub 2003 Oct 12.

15.

The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling.

Sheedy FJ, O'Neill LA.

J Leukoc Biol. 2007 Aug;82(2):196-203. Epub 2007 Apr 20. Review.

PMID:
17449723
16.

Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.

Dunne A, Ejdeback M, Ludidi PL, O'Neill LA, Gay NJ.

J Biol Chem. 2003 Oct 17;278(42):41443-51. Epub 2003 Jul 29.

17.

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S.

Science. 2003 Aug 1;301(5633):640-3. Epub 2003 Jul 10.

18.

Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.

Hise AG, Daehnel K, Gillette-Ferguson I, Cho E, McGarry HF, Taylor MJ, Golenbock DT, Fitzgerald KA, Kazura JW, Pearlman E.

J Immunol. 2007 Jan 15;178(2):1068-76.

20.

Signalling adaptors used by Toll-like receptors: an update.

Kenny EF, O'Neill LA.

Cytokine. 2008 Sep;43(3):342-9. doi: 10.1016/j.cyto.2008.07.010. Epub 2008 Aug 15. Review.

PMID:
18706831

Supplemental Content

Support Center